NASH and Systemic Complications: From Basic to Clinical Research.
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
14 Dec 2021
14 Dec 2021
Historique:
received:
06
12
2021
accepted:
08
12
2021
entrez:
24
12
2021
pubmed:
25
12
2021
medline:
25
12
2021
Statut:
epublish
Résumé
Nonalcoholic fatty liver disease (NAFLD) is known as the hepatic manifestation of the metabolic syndrome, and while most patients develop simple steatosis, up to one-third can develop nonalcoholic steatohepatitis (NASH) [...].
Identifiants
pubmed: 34944726
pii: biomedicines9121913
doi: 10.3390/biomedicines9121913
pmc: PMC8698260
pii:
doi:
Types de publication
Editorial
Langues
eng
Références
Biomedicines. 2020 Sep 14;8(9):
pubmed: 32937969
Biomedicines. 2020 Nov 27;8(12):
pubmed: 33261113
Biomedicines. 2021 Feb 03;9(2):
pubmed: 33546191
Biomedicines. 2021 Jun 30;9(7):
pubmed: 34209386
Biomedicines. 2021 Feb 12;9(2):
pubmed: 33673113
Biomedicines. 2021 Jan 27;9(2):
pubmed: 33513920
Biomedicines. 2020 Feb 08;8(2):
pubmed: 32046285
Biomedicines. 2020 Aug 21;8(9):
pubmed: 32839409
Biomedicines. 2020 Jul 21;8(7):
pubmed: 32708059
Biomedicines. 2021 Mar 02;9(3):
pubmed: 33801289
Biomedicines. 2021 Jan 19;9(1):
pubmed: 33477873
Biomedicines. 2021 Mar 30;9(4):
pubmed: 33808404